Takeda Pharmaceutical (TAK) Inventory (2017 - 2026)

Takeda Pharmaceutical's Inventory history runs 10 years deep, the most recent figure standing at $8.9 billion for Q1 2026.

• In Q1 2026, Inventory rose 11.61% year-over-year to $8.9 billion; the TTM figure through Mar 2026 stood at $8.9 billion (up 11.61% YoY), while the FY2026 annual figure was $9.3 billion, up 16.1% from the prior year.
• Inventory was $8.9 billion for Q1 2026 at Takeda Pharmaceutical, down from $9.1 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $9.1 billion in Q4 2025 to a low of $6.6 billion in Q4 2022.
• Historically, Inventory has averaged $8.0 billion across 5 years, with a median of $8.0 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Inventory slipped 8.04% in 2022, then gained 20.56% in 2023.
• A 5-year view of Inventory shows it stood at $6.6 billion in 2022, then increased by 20.56% to $7.9 billion in 2023, then gained by 3.61% to $8.2 billion in 2024, then rose by 11.53% to $9.1 billion in 2025, then decreased by 2.6% to $8.9 billion in 2026.
• The last three Inventory figures came in at $8.9 billion (Q1 2026), $9.1 billion (Q4 2025), and $8.8 billion (Q3 2025), per Business Quant data.